$CLOV News

Clover Health to Participate in Upcoming UBS Global Healthcare Conference

Clover Health Earns Top Honors in U.S. News & World Report's 2027 Medicare Advantage Ratings Across Three States

Clover Health: Star Plan Rating Buoys It - Why I'm (Cautiously) Long-Term Bullish

Clover Health Investments (CLOV) Is Up 9.4% After Securing 5-Star PPO CMS Rating For 2027

Clover Health (CLOV) Stock Looks In Line Despite 5 Star Medicare News

Why Is Clover Health (CLOV) Stock Soaring Today

Is Clover Health Stock Too Dependent On One Group Of Members?

Clover Health Stock Pops: What's Happening?

Humana, Clover Soar On Medicare Advantage Star Rating; These Stocks Sink

Clover Health Medicare Advantage PPO Plans Earn 5 Star Rating for 2027

At 67, He’ll Keep His Clover Medicare Advantage Plan for 2027. The Premium Will Stay $0. The Most He Can Be Billed Will Jump $1,144

Clover Health to Report Third Quarter 2026 Financial Results on November 4, 2026

Clover Health Investments (CLOV) Unveils 2027 Medicare Plans, Is The Stock Still Cheap?

Clover Health’s 2027 Medicare Advantage Plans Emphasize PPO Choice, Preventive Care and Member Value

UPDATE – Clover Health Welcomes Former U.S. Senator Robert Torricelli and Dr. Brian J. Miller M.D. to Its Board of Directors

Clover Health Welcomes Former U.S. Senator Robert Torricelli and MedPAC Commissioner Dr. Brian J. Miller M.D. to Its Board of Directors

Clover Health Sees PPO Edge, Cohort Gains as Medicare Advantage Pricing Tightens

Clover Health (CLOV) Gets New ‘Buy’ Call, Higher PT, Climbs 8.5%

Clover Health (CLOV) Shares Skyrocket, What You Need To Know

Clover Health (CLOV) Turns Profitable As Medicare Membership Explodes